Former pharmaceutical industry executives with a unique combination of experience in large, mid-sized, and small pharmaceutical and biotechnology companies announce today the launch of BioEndpoint ...

Pharmaceutical Product Development (Nasdaq:PPDI) hit a new 52-week high Wednesday as it changed hands at $30.79 compared with its previous 52-week high of $30.36. Pharmaceutical Product Development is ...

Aurobindo's wholly owned subsidiary, Aurobindo Pharma USA, has entered into a collaboration and license agreement with an unnamed global pharma company for the development and commercialization of ...

RegeneRx and Lee’s Pharmaceutical (HK) Complete License Agreement for Development of RegeneRx Product Candidates in China (including Hong Kong and Macau) and Taiwan (“the Company” or “RegeneRx”) today ...

The global contract research organization will invest $63.7 million to expand its bioanalytical lab in Henrico County, VA. Pharmaceutical Product Development, LLC (PPD), a global contract research ...

Antares Announces Worldwide Development and License Agreement with Jazz Pharmaceuticals EWING, N.J. -- Antares Pharma announced that it has signed a worldwide product development and license agreement ...

Halo Pharma will become a stand-alone business as a result of the sale of the Noramco API and associated business to Siegfried. WHIPPANY, N.J., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Halo Pharma, a leading ...

Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product ...

Shares of Pharmaceutical Product Development (Nasdaq:PPDI) were gapping up Monday morning with an open price 14.2% higher than Friday's closing price. The stock closed at $27.86 yesterday and opened ...

For breakthrough product development, Pharmaceutical Quality System (PQS) requirements need to be followed while supplying suitable flexibility to suit accelerated activities for breakthrough product ...

ADDoPT (Advanced Digital Design of Pharmaceutical Therapeutics) is a major U.K.-led supply chain project established in response to the challenges currently faced by the pharmaceuticals and healthcare ...